scispace - formally typeset
A

Angela R. Hess

Researcher at Northwestern University

Publications -  23
Citations -  5575

Angela R. Hess is an academic researcher from Northwestern University. The author has contributed to research in topics: Vasculogenic mimicry & Melanoma. The author has an hindex of 17, co-authored 23 publications receiving 5221 citations. Previous affiliations of Angela R. Hess include Roy J. and Lucille A. Carver College of Medicine & University of Iowa.

Papers
More filters
Journal ArticleDOI

Vascular Channel Formation by Human Melanoma Cells in Vivo and in Vitro: Vasculogenic Mimicry

TL;DR: It is suggested that aggressive melanoma cells may generate vascular channels that facilitate tumor perfusion independent of tumor angiogenesis, providing a biomechanical explanation for the generation of microvessels in vitro.
Journal ArticleDOI

Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma

TL;DR: The gene expression profile of aggressive cutaneous and uveal melanoma cells resembles that of an undifferentiated, embryonic-like cell as mentioned in this paper, which has been termed "vasculogenic mimicry".
Journal ArticleDOI

Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness.

TL;DR: It is shown that aggressive melanoma cells secrete Nodal (a potent embryonic morphogen) and consequently can induce ectopic formation of the embryonic axis, and thus may be involved in melanoma pathogenesis.
Journal ArticleDOI

Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry

TL;DR: Down-regulation of VE-cadherin expression in the aggressive melanoma cells abrogated their ability to form vasculogenic networks and directly tested the hypothesis that VE -caderin is critical in melanoma vasculogen mimicry.
Journal ArticleDOI

Lysyl Oxidase Regulates Breast Cancer Cell Migration and Adhesion through a Hydrogen Peroxide–Mediated Mechanism

TL;DR: The results suggest that LOX facilitates migration and cell-matrix adhesion formation in invasive breast cancer cells through a hydrogen peroxide-mediated mechanism involving the FAK/Src signaling pathway, and show the need to target LOX for treatment of aggressive breast cancer.